- ICH Q1E sets the statistical rules for turning stability data into a retest period or shelf life.
- Shelf life is the earliest time the 95% confidence bound for the mean crosses the acceptance criterion; batches are pooled only if they pass a test at the 0.25 significance level.
- Extrapolation beyond long-term data is capped: up to 2X and no more than 12 extra months for room temperature products, less for refrigerated products, and none when significant change occurs.
- The free estimator below runs the regression, the poolability tests, and the extrapolation cap on your own data.
ICH Q1E Shelf-Life Estimator
Paste stability results, set the acceptance criterion, and get a Q1E-style estimate. Runs in your browser; data is not sent anywhere.
Comma or tab separated. Paste straight from Excel. Header rows are ignored. Two columns (month, result) are treated as one batch.
Educational tool based on ICH Q1E principles: linear regression, one-sided 95% bounds (two-sided when the attribute can move either way), ANCOVA poolability tests at 0.25, and the Appendix A extrapolation limits for data that are amenable to and supported by statistical analysis. It assumes linear change, normal residuals, and long-term data only. It is not validated software and does not replace a documented statistical analysis.
What is ICH Q1E?
ICH Q1E, Evaluation of Stability Data, is the guideline that explains how to turn stability results into a proposed retest period or shelf life. It sits under ICH Q1A(R2), which defines how stability studies are run, and answers the next question: what shelf life do the data actually support? FDA issued Q1E as guidance in June 2004. It applies to new drug substances and products, and its logic shapes how reviewers read every stability section submitted to support the written stability program required by 21 CFR 211.166.
Q1E covers three decisions: how to model change over time, whether batches can be combined, and how far beyond the available long-term data a shelf life can be extended.
How ICH Q1E estimates shelf life
For attributes that change over time, Q1E recommends regression analysis. The shelf life is the earliest time at which the 95% confidence limit for the mean intersects the acceptance criterion. For an attribute expected to decrease, such as assay, that is the one-sided lower limit. For one expected to increase, such as a degradation product, it is the one-sided upper limit. If the direction is unknown, two-sided limits are used.
With three or more batches, Q1E calls for testing whether they can be pooled. First, an analysis of covariance tests whether the slopes are equal; if not, the shelf life is based on the worst batch. If the slopes are equal, a second test checks the intercepts. Both tests use a 0.25 significance level, which deliberately makes pooling harder to justify. The estimator above runs both tests and tells you which model it used.
ICH Q1E extrapolation limits
Extrapolation means proposing a shelf life (Y) longer than the period covered by long-term data (X). Q1E allows it only within these limits, and only when the data are amenable to statistical analysis and the analysis supports the proposal:
| Storage | Accelerated / intermediate results | Maximum proposed shelf life (Y) |
|---|---|---|
| Room temperature | No significant change at accelerated | Up to 2X, not more than X + 12 months |
| Room temperature | Significant change at accelerated, none at intermediate | Up to 1.5X, not more than X + 6 months |
| Room temperature | Significant change at intermediate | No extrapolation (Y = X or shorter) |
| Refrigerated | No significant change at accelerated | Up to 1.5X, not more than X + 6 months |
| Refrigerated | Significant change at accelerated | No extrapolation; based on long-term data |
| Frozen | Not applicable | Based on long-term data |
Any extrapolated shelf life should be confirmed with long-term data as they become available.
Is ICH Q1E being replaced?
ICH is folding Q1A to Q1F and Q5C into one revised ICH Q1 guideline, and the former Q1E content moves into an expanded annex on stability modelling. The draft reached Step 2 in April 2025, and the ICH Q1 work plan targets Step 4 adoption in November 2026. Until regional regulators implement the new guideline, Q1E remains the reference for current submissions, and its core statistical approach carries into the revision.
Common ICH Q1E mistakes in submissions
- Pooling batches without running the poolability tests, or running them at 0.05 instead of 0.25.
- Extrapolating past the Appendix A limits, or extrapolating when accelerated data showed significant change.
- Using a two-sided bound when the attribute clearly moves in one direction, or the reverse.
- Too few time points or too short a study to estimate the slope with useful precision.
- Ignoring a batch with a steeper slope because the pooled result looks better.
Many of these problems start in study design. Our article on stability study design pitfalls covers how to avoid them, and our quality control and analytics and process development teams support stability programs from protocol to submission.
DES Pharma designs stability programs, runs Q1E evaluations, and writes the stability sections reviewers read first.
Request a meetingICH Q1E FAQ
What is ICH Q1E?
ICH Q1E, Evaluation of Stability Data, is the ICH guideline that explains how to use stability results to propose a retest period or shelf life. It covers regression analysis, confidence limits, testing whether batches can be pooled, and how far a shelf life can be extrapolated beyond the available long-term data. FDA adopted it as guidance in June 2004.
Is ICH Q1E being replaced?
Yes, eventually. ICH is consolidating Q1A to Q1F and Q5C into a single revised ICH Q1 guideline, with the former Q1E content moving into an expanded annex on stability modelling. The draft was released for consultation in April 2025, and the ICH work plan targets Step 4 adoption in November 2026. Until the new guideline is adopted and implemented by FDA and other regulators, Q1E remains the current reference.
Why does ICH Q1E use a 0.25 significance level for pooling?
The pooling test checks whether batches share a common slope and intercept. Q1E sets the significance level at 0.25 rather than the usual 0.05 so the test is more sensitive to real differences between batches. That makes it harder to pool batches that do not belong together, which protects against an optimistic shelf life.
How far can you extrapolate shelf life under ICH Q1E?
For a product stored at room temperature with no significant change at accelerated conditions, and data that support statistical analysis, the proposed shelf life can be up to twice the long-term data period, but no more than 12 months beyond it. Refrigerated products are limited to 1.5 times the data period and no more than 6 months beyond it. If significant change occurs at accelerated or intermediate conditions, the limits shrink or extrapolation is not allowed.
Can I use this calculator for a regulatory submission?
Use it to check a proposal or plan a stability program, not as the analysis of record. A submission needs validated statistical software, a documented analysis plan, and justification for the model, the acceptance criteria, and any extrapolation. Biotechnological products follow ICH Q5C, which generally expects real-time data at the intended storage condition.
About DES Pharma Consulting. DES Pharma Consulting (Dynamic Engineering Solutions) supports drug, biologic, and advanced therapy developers with CMC strategy, analytical development, quality control, quality assurance, process development, and supply chain programs, from early development through commercial manufacturing. Contact our team to discuss your program.




